Lowering urate cuts cardiovascular deathsHyperuricemia deserves more aggressive treatment, researcher says Osteoporosis: There’s an app for thatNew Canadian guidelines offer a choice of risk assessment tools Uloric: first new option for gout in more than 40 years Takeda Canada will soon be introducing Uloric (febuxostat 80 mg) tablets, the first new drug to be marketed for gout in more than four decades. Men and Women's Health 2010: Osteoporosis New developments in therapy, vitamin D requirements, bisphosphonate safety and risk assessment. Actemra: anaphylaxis risk Hoffmann-La Roche and Health Canada warn about potential risk of fatal anaphylaxis with Actemra (tocilizumab). Arthritis care benefits from team approach Leading Ontario clinic spreading its model of chronic disease management across Canada Rheumatoid arthritis redefined Canadian doctor played a major role in international effort to overhaul RA criteria New drugs on the way for gout Experimental compounds control pain and reduce serum uric acid levels Cherries aid gout treatment Consider concentrated juice as an adjunct to urate-lowering therapy, researcher says Drinking decreases arthritis risk Study links alcohol consumption with reduced likelihood of several inflammatory conditions First Previous 18 19 20 21 Next Last
